R. P. Baughman, A. S. Teirstein, M. A. Judson, M. D. Rossman, H. Yeager et al., Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.15, issue.10, pp.1885-1894, 2001.
DOI : 10.1016/0002-9343(71)90320-2

G. Hillerdal, E. Nou, K. Osterman, and B. Schmekel, Sarcoidosis: epidemiology and prognosis. A 15-year European study, Am Rev Respir Dis, vol.130, pp.29-32, 1984.

N. Milman and O. Selroos, Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture, Sarcoidosis, vol.7, pp.50-57, 1990.

B. A. Rybicki, M. Major, J. Popovich, . Jr, M. J. Maliarik et al., Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization, American Journal of Epidemiology, vol.145, issue.3, pp.234-275, 1997.
DOI : 10.1093/oxfordjournals.aje.a009096

F. Bardinas, J. Morera, E. Fite, and A. Plasencia, Seasonal clustering of sarcoidosis, Lancet, vol.2, pp.455-461, 1989.

A. Pietinalho, M. Ohmichi, Y. Hiraga, A. B. Lofroos, and O. Selroos, The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients, Sarcoidosis Vasc Diffuse Lung Dis, vol.13, pp.159-66, 1996.

A. Z. Keller, HOSPITAL, AGE, RACIAL, OCCUPATIONAL, GEOGRAPHICAL, CLINICAL AND SURVIVORSHIP CHARACTERISTICS IN THE EPIDEMIOLOGY OF SARCOIDOSIS, American Journal of Epidemiology, vol.94, issue.3, pp.222-252, 1971.
DOI : 10.1093/oxfordjournals.aje.a121316

A. Perry and F. Vuitch, Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations, Arch Pathol Lab Med, vol.119, pp.167-72, 1995.

K. Iwai, T. Tachibana, T. Takemura, Y. Matsui, M. Kitaichi et al., Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan, Pathology International, vol.8, issue.Suppl. 5, pp.372-378, 1993.
DOI : 10.1038/bjc.1986.199

K. Iwai, T. Takemura, M. Kitaichi, Y. Kawabata, and Y. Matsui, Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern, Pathology International, vol.2, issue.7-8, pp.377-85, 1993.
DOI : 10.1164/ajrccm/142.1.238

G. N. Mannino and D. M. , Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data, Am J Med, vol.100, pp.423-430, 1996.

B. A. Rybicki, M. C. Iannuzzi, M. M. Frederick, B. W. Thompson, M. D. Rossman et al., Familial Aggregation of Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.123, issue.11, pp.2085-91, 2001.
DOI : 10.1016/0895-4356(88)90060-1

B. A. Rybicki, K. L. Kirkey, M. Major, M. J. Maliarik, J. Popovich et al., Familial Risk Ratio of Sarcoidosis in African-American Sibs and Parents, American Journal of Epidemiology, vol.153, issue.2, pp.188-93, 2001.
DOI : 10.1111/j.1469-1809.1965.tb00500.x

M. Schurmann, P. Reichel, B. Muller-myhsok, M. Schlaak, J. Muller-quernheim et al., Results from a Genome-wide Search for Predisposing Genes in Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.15, issue.5
DOI : 10.1093/oxfordjournals.jncimonographs.a024226

M. Schurmann, P. A. Lympany, P. Reichel, B. Muller-myhsok, K. Wurm et al., Familial Sarcoidosis Is Linked to the Major Histocompatibility Complex Region, American Journal of Respiratory and Critical Care Medicine, vol.141, issue.3, pp.861-865, 2000.
DOI : 10.1016/0198-8859(96)82496-7

H. Sato, F. A. Woodhead, T. Ahmad, J. C. Grutters, P. Spagnolo et al., Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups, Human Molecular Genetics, vol.262, issue.20, pp.4100-4111
DOI : 10.1111/j.1365-2796.2007.01829.x

A. Morais, H. Alves, B. Lima, L. Delgado, R. Goncalves et al., Estudo de polimorfismos gen??ticos do HLA (classes I e II) e do TNF-?? em doentes com sarcoidose, Revista Portuguesa de Pneumologia, vol.14, issue.6, pp.727-773, 2008.
DOI : 10.1016/S0873-2159(15)30284-1

URL : https://doi.org/10.1016/s0873-2159(15)30284-1

A. Pietinalho, K. Furuya, E. Yamaguchi, Y. Kawakami, and O. Selroos, The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients, European Respiratory Journal, vol.13, issue.4, pp.723-729, 1999.
DOI : 10.1034/j.1399-3003.1999.13d04.x

K. Furuya, E. Yamaguchi, A. Itoh, N. Hizawa, N. Ohnuma et al., Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis., Thorax, vol.51, issue.8, pp.777-80, 1996.
DOI : 10.1136/thx.51.8.777

D. S. Mcgrath, P. J. Foley, M. Petrek, L. Izakovicova-holla, V. Kolek et al., ACE Gene I/D Polymorphism and Sarcoidosis Pulmonary Disease Severity, American Journal of Respiratory and Critical Care Medicine, vol.51, issue.2, pp.197-201, 2001.
DOI : 10.1093/hmg/7.11.1745

H. Tomita, Y. Ina, Y. Sugiura, S. Sato, H. Kawaguchi et al., Polymorphism in the Angiotensin-Converting Enzyme (ACE) Gene and Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.690, issue.1, pp.255-264, 1997.
DOI : 10.1016/0002-9343(81)90410-1

M. W. Ziegenhagen and J. Muller-quernheim, The cytokine network in sarcoidosis and its clinical relevance, Journal of Internal Medicine, vol.163, issue.1, pp.18-30, 2003.
DOI : 10.1056/NEJMoa011110

A. G. Wilson, N. De-vries, F. Pociot, F. S. Di-giovine, L. B. Van-der-putte et al., An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles, Journal of Experimental Medicine, vol.177, issue.2, pp.557-60, 1993.
DOI : 10.1084/jem.177.2.557

A. Somoskovi, G. Zissel, U. Seitzer, J. Gerdes, M. Schlaak et al., Polymorphisms at position -308 in the promoter region of the TNF-alpha and in the first Page, p.73

R. Valentonyte, J. Hampe, K. Huse, P. Rosenstiel, M. Albrecht et al., Sarcoidosis is associated with a truncating splice site mutation in BTNL2, Nature Genetics, vol.124, issue.4, pp.357-64, 2005.
DOI : 10.1053/gast.2003.50157

S. E. Hills, S. A. Parkes, and S. B. Baker, Epidemiology of sarcoidosis in the Isle of Man--2: Evidence for space-time clustering., Thorax, vol.42, issue.6, pp.427-457, 1987.
DOI : 10.1136/thx.42.6.427

S. A. Parkes, S. B. Baker, R. E. Bourdillon, C. R. Murray, M. Rakshit et al., Incidence of sarcoidosis in the Isle of Man., Thorax, vol.40, issue.4, pp.284-291, 1985.
DOI : 10.1136/thx.40.4.284

S. Panayeas, P. Theodorakopoulos, A. Bouras, and S. Constantopoulos, Seasonal occurrence of sarcoidosis in Greece, The Lancet, vol.338, issue.8765, pp.510-511, 1991.
DOI : 10.1016/0140-6736(91)90581-9

D. G. Kern, M. A. Neill, D. S. Wrenn, and J. C. Varone, Investigation of a Unique Time-Space Cluster of Sarcoidosis in Firefighters, American Review of Respiratory Disease, vol.17, issue.4_pt_1, pp.974-80, 1993.
DOI : 10.1136/thx.45.7.536

P. E. Sartwell and L. B. Edwards, EPIDEMIOLOGY OF SARCOIDOSIS IN THE U. S. NAVY1, American Journal of Epidemiology, vol.99, issue.4, pp.250-257, 1974.
DOI : 10.1093/oxfordjournals.aje.a121609

B. A. Rybicki, K. L. Amend, M. J. Maliarik, and M. C. Iannuzzi, Photocopier exposure and risk of sarcoidosis in African-American sibs, Sarcoidosis Vasc Diffuse Lung Dis, vol.21, pp.49-55, 2004.

L. S. Newman, C. S. Rose, E. A. Bresnitz, M. D. Rossman, J. Barnard et al., A Case Control Etiologic Study of Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.12
DOI : 10.1164/rccm.200210-1154OC

G. P. Kucera, B. A. Rybicki, K. L. Kirkey, S. W. Coon, M. L. Major et al., Occupational Risk Factors for Sarcoidosis in African-American Siblings, Chest, vol.123, issue.5, pp.1527-1562, 2003.
DOI : 10.1378/chest.123.5.1527

W. M. Burke, A. Keogh, P. J. Maloney, W. Delprado, D. H. Bryant et al., Transmission of sarcoidosis via cardiac transplantation, The Lancet, vol.336, issue.8730-8731, p.1579, 1990.
DOI : 10.1016/0140-6736(90)93354-R

A. Heyll, G. Meckenstock, C. Aul, D. Sohngen, F. Borchard et al., Possible transmission of sarcoidosis via allogeneic bone marrow transplantation, Bone Marrow Transplant, vol.14, pp.161-165, 1994.

D. G. James and W. J. Williams, Kveim-Siltzbach test revisited, Sarcoidosis, vol.8, pp.6-9, 1991.

I. Ishige, Y. Usui, T. Takemura, and Y. Eishi, Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis, The Lancet, vol.354, issue.9173, pp.120-123, 1999.
DOI : 10.1016/S0140-6736(98)12310-3

M. Conron, D. Bois, and R. M. , Immunological mechanisms in sarcoidosis, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.46, issue.4, pp.543-54, 2001.
DOI : 10.1056/NEJM199901283400401

P. Pinkston, P. B. Bitterman, and R. G. Crystal, Spontaneous Release of Interleukin-2 by Lung T Lymphocytes in Active Pulmonary Sarcoidosis, New England Journal of Medicine, vol.308, issue.14, pp.793-800, 1983.
DOI : 10.1056/NEJM198304073081401

K. Shigehara, N. Shijubo, M. Ohmichi, R. Takahashi, S. Kon et al., IL-12 and IL-18 Are Increased and Stimulate IFN-?? Production in Sarcoid Lungs, The Journal of Immunology, vol.166, issue.1, pp.642-651, 2001.
DOI : 10.4049/jimmunol.166.1.642

I. Baumer, G. Zissel, M. Schlaak, J. Muller-quernheim, and . Th1, Th1/Th2 cell distribution in pulmonary sarcoidosis., American Journal of Respiratory Cell and Molecular Biology, vol.16, issue.2, pp.171-178, 1997.
DOI : 10.1165/ajrcmb.16.2.9032124

C. Agostini, F. Adami, and G. Semenzato, New pathogenetic insights into the sarcoid granuloma, Current Opinion in Rheumatology, vol.12, issue.1, pp.71-77, 2000.
DOI : 10.1097/00002281-200001000-00012

G. Zissel, A. Prasse, and J. Muller-quernheim, Sarcoidosis-Immunopathogenetic Concepts, Seminars in Respiratory and Critical Care Medicine, vol.28, issue.1
DOI : 10.1055/s-2007-970329

P. Soler and F. Basset, MORPHOLOGY AND DISTRIBUTION OF THE CELLS OF A SARCOID GRANULOMA: ULTRASTRUCTURAL STUDY OF SERIAL SECTIONS, Annals of the New York Academy of Sciences, vol.223, issue.1 Seventh Inter, pp.147-60, 1976.
DOI : 10.1002/path.1711050305

R. P. Baughman, S. A. Strohofer, J. Buchsbaum, and E. E. Lower, Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis, J Lab Clin Med, vol.115, pp.36-42, 1990.

J. P. Lynch, T. J. Standiford, M. W. Rolfe, S. L. Kunkel, and R. M. Strieter, Neutrophilic Alveolitis in Idiopathic Pulmonary Fibrosis: The Role of Interleukin-8, American Review of Respiratory Disease, vol.243, issue.6, pp.1433-1442, 1992.
DOI : 10.1084/jem.164.6.2113

J. Wahlstrom, K. Katchar, H. Wigzell, O. Olerup, A. Eklund et al., Lung and Blood T Cells in Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.27, issue.1, pp.115-136, 2001.
DOI : 10.1164/ajrccm.154.3.8810610

A. Prasse, D. V. Pechkovsky, G. B. Toews, W. Jungraithmayr, F. Kollert et al., A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.7, pp.781-92, 2006.
DOI : 10.1164/rccm.200504-644OC

R. P. Baughman, E. E. Lower, and R. M. Du-bois, Sarcoidosis, The Lancet, vol.361, issue.9363, pp.1111-1119, 2003.
DOI : 10.1016/S0140-6736(03)12888-7

P. Soler, Pathogénie-étiologie de la sarcoidose, Ann Med Interne (Paris), vol.152, pp.28-33, 2001.

T. Takemura, Y. Matsui, S. Saiki, and R. Mikami, Pulmonary vascular involvement in sarcoidosis: A report of 40 autopsy cases, Human Pathology, vol.23, issue.11, pp.1216-1239, 1992.
DOI : 10.1016/0046-8177(92)90288-E

J. P. Battesti and E. Azoulay, Formes atypiques de sarcoidose, Ann Med Interne (Paris), vol.152, pp.51-58, 2001.

P. Grenier, S. Chevret, C. Beigelman, M. W. Brauner, C. Chastang et al., Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis., Radiology, vol.191, issue.2, pp.383-90, 1994.
DOI : 10.1148/radiology.191.2.8153310

J. P. Lynch, E. A. Kazerooni, and S. E. Gay, PULMONARY SARCOIDOSIS, Clinics in Chest Medicine, vol.18, issue.4, pp.755-85, 1997.
DOI : 10.1016/S0272-5231(05)70417-2

M. W. Brauner, P. Grenier, D. Mompoint, S. Lenoir, and H. De-cremoux, Pulmonary sarcoidosis: evaluation with high-resolution CT., Radiology, vol.172, issue.2, pp.467-71, 1989.
DOI : 10.1148/radiology.172.2.2748828

J. P. Battesti, G. Saumon, D. Valeyre, J. Amouroux, B. Pechnick et al., Pulmonary sarcoidosis with an alveolar radiographic pattern., Thorax, vol.37, issue.6, pp.448-52, 1982.
DOI : 10.1136/thx.37.6.448

A. Tazi, T. Desfemmes-baleyte, P. Soler, D. Valeyre, A. J. Hance et al., Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph., Thorax, vol.49, issue.8, pp.793-800, 1994.
DOI : 10.1136/thx.49.8.793

M. Abehsera, D. Valeyre, P. Grenier, H. Jaillet, J. P. Battesti et al., Sarcoidosis with Pulmonary Fibrosis, American Journal of Roentgenology, vol.174, issue.6, pp.1751-1758, 2000.
DOI : 10.2214/ajr.174.6.1741751

M. W. Brauner, S. Lenoir, P. Grenier, P. Cluzel, J. P. Battesti et al., Pulmonary sarcoidosis: CT assessment of lesion reversibility., Radiology, vol.182, issue.2, pp.349-54, 1992.
DOI : 10.1148/radiology.182.2.1732948

J. Murdoch and N. L. Muller, Pulmonary sarcoidosis: changes on follow-up CT examination., American Journal of Roentgenology, vol.159, issue.3
DOI : 10.2214/ajr.159.3.1503008

URL : http://www.ajronline.org/doi/pdf/10.2214/ajr.159.3.1503008

S. Abe, M. Munakata, M. Nishimura, Y. Tsuneta, T. Terai et al., Gallium-67 Scintigraphy, Bronchoalveolar Lavage, and Pathologic Changes in Patients with Pulmonary Sarcoidosis, Chest, vol.85, issue.5, pp.650-655, 1984.
DOI : 10.1378/chest.85.5.650

B. Wallaert, P. Ramon, E. Fournier, A. B. Tonnel, and C. Voisin, Bronchoalveolar Lavage, Serum Angiotensin-converting Enzyme, and Gallium-67 Scanning in Extrathoracic Sarcoidosis, Chest, vol.82, issue.5, pp.553-558, 1982.
DOI : 10.1378/chest.82.5.553

A. Tremblay, D. R. Stather, P. Maceachern, M. Khalil, and S. K. Field, A Randomized Controlled Trial of Standard vs Endobronchial Ultrasonography-Guided Transbronchial Needle Aspiration in Patients With Suspected Sarcoidosis, Chest, vol.136, issue.2, pp.340-346, 2009.
DOI : 10.1378/chest.08-2768

U. Costabel and . Cd4, CD4/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis?, European Respiratory Journal, vol.10, issue.12, pp.2699-700, 1997.
DOI : 10.1183/09031936.97.10122699

R. S. Levinson, L. F. Metzger, N. N. Stanley, S. G. Kelsen, M. D. Altose et al., Airway function in sarcoidosis, The American Journal of Medicine, vol.62, issue.1, pp.51-60, 1977.
DOI : 10.1016/0002-9343(77)90349-7

C. Lamberto, H. Nunes, L. Toumelin, P. Duperron, F. Valeyre et al., Membrane and Capillary Blood Components of Diffusion Capacity of the Lung for Carbon Monoxide in Pulmonary Sarcoidosis, Chest, vol.125, issue.6, pp.2061-2069, 2004.
DOI : 10.1378/chest.125.6.2061

K. Viskum and J. Vestbo, Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage, Eur Respir J, vol.6, pp.349-53, 1993.

V. Descamps, F. Bouscarat, and E. Marinho, Manifestations cutanées de la sarcoïdose, Encycl Med Chir, pp.98-470, 2005.

R. J. Young, R. T. Gilson, D. Yanase, and D. M. Elston, Cutaneous sarcoidosis, International Journal of Dermatology, vol.61, issue.4, pp.249-53, 2001.
DOI : 10.1378/chest.61.4.320

T. J. Giuffrida and F. A. Kerdel, Sarcoidosis, Dermatologic Clinics, vol.20, issue.3, pp.435-482, 2002.
DOI : 10.1016/S0733-8635(02)00010-4

A. A. Bonfioli and F. Orefice, Sarcoidosis, Seminars in Ophthalmology, vol.101, issue.5, pp.177-82, 2005.
DOI : 10.1001/archopht.1983.01040010559004

A. Rothova, Ocular involvement in sarcoidosis, British Journal of Ophthalmology, vol.84, issue.1, pp.110-116, 2000.
DOI : 10.1136/bjo.84.1.110

I. Badelon and G. Chaine, Les manifestations ophtalmologiques de la sarcoïdose, Ann Med Interne (Paris), vol.152, pp.108-120, 2001.

J. L. Dumas, D. Valeyre, C. Chapelon-abric, C. Belin, J. C. Piette et al., Central Nervous System Sarcoidosis: Follow-up at MR Imaging during Steroid Therapy, Radiology, vol.214, issue.2, pp.411-431, 2000.
DOI : 10.1148/radiology.214.2.r00fe05411

D. Valeyre, C. Chapelon-abric, C. Belin, and J. L. Dumas, Sarco??dose du syst??me nerveux central, La Revue de M??decine Interne, vol.19, issue.6, pp.409-423, 1998.
DOI : 10.1016/S0248-8663(98)80865-5

C. Chapelon-abric, D. De-zuttere, P. Duhaut, P. Veyssier, B. Wechsler et al., Cardiac Sarcoidosis, Medicine, vol.83, issue.6, pp.315-349, 2004.
DOI : 10.1097/01.md.0000145367.17934.75

C. Chapelon-abric and . Sarcoidose-cardiaque, Sarco??doses cardiaques, La Revue de M??decine Interne, vol.28, issue.1, pp.33-38, 2007.
DOI : 10.1016/j.revmed.2007.03.016

T. Suzuki, T. Kanda, S. Kubota, S. Imai, and K. Murata, Holter Monitoring as a Noninvasive Indicator of Cardiac Involvement in Sarcoidosis, Chest, vol.106, issue.4, pp.1021-1025, 1994.
DOI : 10.1378/chest.106.4.1021

N. Uslu, A. Akyol, S. Gorgulu, M. Eren, B. Ocakli et al., Heart Rate Variability in Patients with Systemic Sarcoidosis, Annals of Noninvasive Electrocardiology, vol.41, issue.4, pp.38-42, 2006.
DOI : 10.1016/S0002-8703(99)70115-8

G. J. Fahy, T. Marwick, C. J. Mccreery, P. J. Quigley, and B. J. Maurer, Doppler Echocardiographic Detection of Left Ventricular Diastolic Dysfunction in Patients With Pulmonary Sarcoidosis, Chest, vol.109, issue.1, pp.62-68, 1996.
DOI : 10.1378/chest.109.1.62

A. Meyrier, Sarcoidosis: the nephrologist's view, Ann Med Interne (Paris), vol.152, pp.45-50, 2001.

M. Mahevas, F. X. Lescure, J. J. Boffa, V. Delastour, X. Belenfant et al., Renal Sarcoidosis, Medicine, vol.88, issue.2, pp.98-106, 2009.
DOI : 10.1097/MD.0b013e31819de50f

H. Visser, K. Vos, E. Zanelli, W. Verduyn, G. M. Schreuder et al., Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors, Annals of the Rheumatic Diseases, vol.61, issue.6, pp.499-504, 2002.
DOI : 10.1136/ard.61.6.499

URL : http://ard.bmj.com/content/annrheumdis/61/6/499.full.pdf

K. D. Torralba, F. P. Quismorio, and . Jr, Sarcoid arthritis: a review of clinical features, pathology and therapy, Sarcoidosis Vasc Diffuse Lung Dis, vol.20, pp.95-103, 2003.

J. P. Eschard and J. C. Etienne, Manifestations ostéoarticulaires de la sarcoïdose, Rev Med Interne, vol.15, pp.305-312, 1994.

N. Thelier, N. Assous, C. Job-deslandre, O. Meyer, T. Bardin et al., Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments, J Rheumatol, vol.35, pp.1622-1630, 2008.

N. Thelier and Y. Allanore, Localisations ost??oarticulaires de la sarco??dose, Appareil locomoteur, pp.14-027, 2009.
DOI : 10.1016/S0246-0521(09)48227-5

F. Fayad, F. Liote, F. Berenbaum, P. Orcel, and T. Bardin, Muscle involvement in sarcoidosis: a retrospective and followup studies, J Rheumatol, vol.33, pp.98-103, 2006.

U. K. Shah, J. A. White, J. E. Gooey, and R. L. Hybels, Otolaryngologic Manifestations of Sarcoidosis: Presentation and Diagnosis, The Laryngoscope, vol.106, issue.1, pp.67-75, 1997.
DOI : 10.1002/lary.5540861214

J. F. Zeitlin, T. A. Tami, R. Baughman, and D. Winget, Nasal and Sinus Manifestations of Sarcoidosis, American Journal of Rhinology, vol.14, issue.3, pp.157-61, 2000.
DOI : 10.2500/105065800782102753

A. Meybeck, N. Just, F. Heurtebise, P. Chanez, L. Crampette et al., Atteinte nasosinusienne au cours de la sarco??dose, Revue des Maladies Respiratoires, vol.21, issue.2, pp.279-86, 2004.
DOI : 10.1016/S0761-8425(04)71286-3

. Granulomatose-nécrosante-sarcoid-like, A propos de 4 cas, Ann Med Interne, vol.145, pp.230-233, 1994.

E. A. Hurst and T. Mauro, Sarcoidosis Associated With Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C, Archives of Dermatology, vol.141, issue.7, pp.865-873, 2005.
DOI : 10.1001/archderm.141.7.865

H. J. Goldberg, D. Fiedler, A. Webb, J. Jagirdar, A. M. Hoyumpa et al., Sarcoidosis after treatment with interferon-??: A case series and review of the literature, Respiratory Medicine, vol.100, issue.11, pp.2063-2071, 2006.
DOI : 10.1016/j.rmed.2006.03.004

M. Kornacker, A. Kraemer, E. Leo, and A. D. Ho, Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases, Annals of Hematology, vol.81, issue.2, pp.103-108, 2002.
DOI : 10.1007/s00277-001-0415-6

S. Ahbib, J. M. Lachapelle, and L. Marot, Granulomes sarco??dosiques apr??s injections de toxine botulique A (Botox??) pour correction de rides, Annales de Dermatologie et de V??n??r??ologie, vol.133, issue.1, pp.43-48, 2006.
DOI : 10.1016/S0151-9638(06)70842-0

T. Yoshida, M. Tanaka, K. Okamoto, and S. Hirai, Neurosarcoidosis following augmentation mammoplasty with silicone, Neurological Research, vol.18, issue.4, pp.319-339, 1996.
DOI : 10.1080/01616412.1996.11740428

D. Bouvry, Y. Uzunhan, J. M. Naccache, H. Nunes, P. Y. Brillet et al., Sarco??dose ?? pr??sentation atypique, La Revue de M??decine Interne, vol.29, issue.1, pp.46-53, 2008.
DOI : 10.1016/j.revmed.2007.10.005

A. Meyrier, D. Valeyre, R. Bouillon, F. Paillard, J. P. Battesti et al., Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity, Q J Med, vol.54, pp.269-81, 1985.

D. Sandron, D. Lecossier, A. Grodet, G. Basset, and J. P. Battesti, Intérêt pratique du dosage de l'ECA sérique dans la sarcoidose, Rev Fr Mal Respir, vol.8, pp.253-261, 1980.

C. Bergoin, C. Lamblin, and B. Wallaert, Manifestations biologiques au cours de la sarcoidose, Ann Med Interne (Paris), vol.152, pp.34-42, 2001.

H. Nunes, C. Maurer, J. M. Naccache, F. Girard, M. Brauner et al., Sarcoidose pulmonaire sévère, Ann Med Interne, vol.152, pp.96-102, 2001.

G. Rizzato, A. Pezzano, G. Sala, R. Merlini, L. Ladelli et al., Right heart impairment in sarcoidosis: haemodynamic and echocardiographic study, Eur J Respir Dis, vol.64, pp.121-129, 1983.

J. Askling, J. Grunewald, A. Eklund, G. Hillerdal, and A. Ekbom, Increased Risk for Cancer Following Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.2, issue.5, pp.1668-72, 1999.
DOI : 10.1002/ijc.2910510611

J. M. Naccache, M. Antoine, M. Wislez, J. Fleury-feith, E. Oksenhendler et al., Sarcoid-like Pulmonary Disorder in Human Immunodeficiency Virus???infected Patients Receiving Antiretroviral Therapy, American Journal of Respiratory and Critical Care Medicine, vol.128, issue.6, pp.2009-2022, 1999.
DOI : 10.1016/S0140-6736(05)62892-9

F. Bonnet, J. Dubuc, P. Morlat, X. Delbrel, M. S. Doutre et al., Sarco??dose et comorbidit????: ??tude r??trospective de 32 observations, La Revue de M??decine Interne, vol.22, issue.7, pp.619-642, 2001.
DOI : 10.1016/S0248-8663(01)00398-8

H. Brincker and E. Wilbek, The Incidence of Malignant Tumours in Patients with Respiratory Sarcoidosis, British Journal of Cancer, vol.29, issue.3, pp.247-51, 1974.
DOI : 10.1038/bjc.1974.64

F. K. Romer, P. Hommelgaard, and G. Schou, Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients, European Respiratory Journal, vol.12, issue.4, pp.906-918, 1998.
DOI : 10.1183/09031936.98.12040906

N. S. Paramothayan, T. J. Lasserson, and P. W. Jones, Corticosteroids for pulmonary sarcoidosis, Cochrane Database Syst Rev, p.1114, 2005.
DOI : 10.1002/14651858.cd001114

R. P. Baughman and E. E. Lower, The Effect of Corticosteroid or Methotrexate Therapy on Lung Lymphocytes and Macrophages in Sarcoidosis, American Review of Respiratory Disease, vol.1, issue.6_pt_1, pp.1268-71, 1990.
DOI : 10.1126/science.3754653

R. P. Baughman, D. B. Winget, and E. E. Lower, Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial, Sarcoidosis Vasc Diffuse Lung Dis, vol.17, pp.60-66, 2000.

R. P. Baughman and E. E. Lower, A clinical approach to the use of methotrexate for sarcoidosis, Thorax, vol.54, issue.8, pp.742-748, 1999.
DOI : 10.1136/thx.54.8.742

N. K. Veien and H. Brodthagen, Cutaneous sarcoidosis treated with methotrexate, British Journal of Dermatology, vol.21, issue.2, pp.213-219, 1977.
DOI : 10.1001/archderm.108.1.36

R. P. Baughman and E. E. Lower, STEROID-SPARING ALTERNATIVE TREATMENTS FOR SARCOIDOSIS, Clinics in Chest Medicine, vol.18, issue.4, pp.853-64, 1997.
DOI : 10.1016/S0272-5231(05)70423-8

M. Baltzan, S. Mehta, T. H. Kirkham, and M. G. Cosio, Randomized Trial of Prolonged Chloroquine Therapy in Advanced Pulmonary Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.157, issue.1, pp.192-199, 1999.
DOI : 10.1111/j.1365-2249.1995.tb06648.x

O. P. Sharma, Neurosarcoidosis, Chest, vol.112, issue.1, pp.220-228, 1997.
DOI : 10.1378/chest.112.1.220

E. Jones and J. P. Callen, Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas, Journal of the American Academy of Dermatology, vol.23, issue.3, pp.487-496, 1990.
DOI : 10.1016/0190-9622(90)70246-E

Q. Ye, B. Chen, Z. Tong, S. Nakamura, R. Sarria et al., Thalidomide reduces IL-18, IL-8 and TNF-?? release from alveolar macrophages in interstitial lung disease, European Respiratory Journal, vol.28, issue.4, pp.824-855, 2006.
DOI : 10.1183/09031936.06.00131505

R. P. Baughman, M. A. Judson, A. S. Teirstein, D. R. Moller, and E. E. Lower, Thalidomide for Chronic Sarcoidosis, Chest, vol.122, issue.1, pp.227-259, 2002.
DOI : 10.1378/chest.122.1.227

Y. T. Nguyen, A. Dupuy, F. Cordoliani, M. D. Vignon-pennamen, C. Lebbe et al., Treatment of cutaneous sarcoidosis with thalidomide, Journal of the American Academy of Dermatology, vol.50, issue.2, pp.235-276, 2004.
DOI : 10.1016/j.jaad.2003.07.006

J. C. Hoyle, H. B. Newton, and S. Katz, Prognosis of refractory neurosarcoidosis altered by thalidomide: a case report, Journal of Medical Case Reports, vol.57, issue.5, p.27, 2008.
DOI : 10.1212/WNL.57.5.927

M. A. Judson, J. Silvestri, C. Hartung, T. Byars, and C. E. Cox, The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, vol.23, pp.51-58, 2006.

R. P. Baughman and E. E. Lower, Leflunomide for chronic sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, vol.21, pp.43-51, 2004.

J. Muller-quernheim, K. Kienast, M. Held, S. Pfeifer, and U. Costabel, Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen, European Respiratory Journal, vol.14, issue.5, pp.1117-1139, 1999.
DOI : 10.1183/09031936.99.14511179

S. J. Lewis, G. M. Ainslie, and E. D. Bateman, Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, vol.16, pp.87-92, 1999.

L. Varron, C. Broussolle, J. P. Candessanche, R. Marignier, H. Rousset et al., Spinal cord sarcoidosis: report of seven cases, European Journal of Neurology, vol.16, issue.3, pp.289-96, 2009.
DOI : 10.1212/01.WNL.0000034766.13282.33

M. Arai and A. Sugiura, Chronic Relapsing Demyelinating Polyneuropathy Associated with Sarcoidosis: Successful Treatment with Intravenous Pulse Cyclophosphamide., Internal Medicine, vol.40, issue.12, pp.1261-1263, 2001.
DOI : 10.2169/internalmedicine.40.1261

R. H. Israel and R. H. Poe, Massive Pericardial Effusion in Sarcoidosis, Respiration, vol.61, issue.3, pp.176-80, 1994.
DOI : 10.1159/000196333

S. L. Demeter, Myocardial Sarcoidosis Unresponsive to Steroids, Chest, vol.94, issue.1, pp.202-205, 1988.
DOI : 10.1378/chest.94.1.202

C. Bullmann, M. Faust, A. Hoffmann, C. Heppner, F. Jockenhovel et al., Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis, European Journal of Endocrinology, vol.142, issue.4, pp.365-72, 2000.
DOI : 10.1530/eje.0.1420365

J. D. Doty, J. E. Mazur, and M. A. Judson, Treatment of Sarcoidosis With Infliximab, Chest, vol.127, issue.3, pp.1064-71, 2005.
DOI : 10.1378/chest.127.3.1064

D. J. Kouba, D. Mimouni, A. Rencic, and H. C. Nousari, Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis, British Journal of Dermatology, vol.27, issue.1, pp.147-155, 2003.
DOI : 10.1053/jd.1999.v40.a95204

S. Pawate, H. Moses, and S. Sriram, Presentations and outcomes of neurosarcoidosis: a study of 54 cases, QJM: An International Journal of Medicine, vol.72, issue.7, pp.449-60, 2009.
DOI : 10.1212/01.wnl.0000341278.26993.22

B. J. Stern, S. A. Schonfeld, C. Sewell, A. Krumholz, P. Scott et al., The Treatment of Neurosarcoidosis With Cyclosporine, Archives of Neurology, vol.49, issue.10, pp.1065-72, 1992.
DOI : 10.1001/archneur.1992.00530340089023

E. L. York, T. Kovithavongs, S. F. Man, A. S. Rebuck, and B. J. Sproule, Cyclosporine and Chronic Sarcoidosis, Chest, vol.98, issue.4, pp.1026-1035, 1990.
DOI : 10.1378/chest.98.4.1026

Y. Martinet, P. Pinkston, C. Saltini, J. Spurzem, J. Muller-quernheim et al., Effects of Cyclosporine on the Lung T-Lymphocyte Alveolitis of Active Pulmonary Sarcoidosis, American Review of Respiratory Disease, vol.31, issue.5, pp.1242-1250, 1988.
DOI : 10.1097/00007890-198005000-00003

P. Zabel, P. Entzian, K. Dalhoff, and M. Schlaak, Pentoxifylline in treatment of sarcoidosis., American Journal of Respiratory and Critical Care Medicine, vol.155, issue.5
DOI : 10.1164/ajrccm.155.5.9154873

R. G. Barbers, ROLE OF TRANSPLANTATION (LUNG, LIVER, AND HEART) IN SARCOIDOSIS, Clinics in Chest Medicine, vol.18, issue.4, pp.865-74, 1997.
DOI : 10.1016/S0272-5231(05)70424-X

D. B. Bogaerts, Y. Coenegrachts, K. L. , D. Vriese, and A. S. , Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer?, Clin Sci (Lond), vol.112, pp.281-290, 2007.

N. J. Sweiss and R. P. Baughman, Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon?, J Rheumatol, vol.34, pp.2129-2160, 2007.

N. Foley, C. Lambert, M. Mcnicol, N. Johnson, and G. A. Rook, An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease, Clinical & Experimental Immunology, vol.234, issue.3, pp.395-404, 1990.
DOI : 10.1126/science.3764421

T. Hino, H. Nakamura, Y. Shibata, S. Abe, S. Kato et al., Elevated Levels of Type II Soluble Tumor Necrosis Factor Receptors in the Bronchoalveolar Lavage Fluids of Patients with Sarcoidosis, Lung, vol.175, issue.3, pp.187-93, 1997.
DOI : 10.1007/PL00007566

T. Nakayama, S. Hashimoto, E. Amemiya, and T. Horie, Elevation of plasma-soluble tumour necrosis factor receptors (TNF-R) in sarcoidosis, Clinical and Experimental Immunology, vol.104, issue.2, pp.318-342, 1996.
DOI : 10.1046/j.1365-2249.1996.13702.x

J. Muller-quernheim, S. Pfeifer, D. Mannel, J. Strausz, and R. Ferlinz, Lung-restricted Activation of the Alveolar Macrophage/Monocyte System in Pulmonary Sarcoidosis, American Review of Respiratory Disease, vol.107, issue.1, pp.187-92, 1992.
DOI : 10.1038/344245a0

M. W. Ziegenhagen, J. Fitschen, N. Martinet, M. Schlaak, and J. Muller-quernheim, Serum level of soluble tumour necrosis factor receptor II (75 kDa) indicates inflammatory activity of sarcoidosis, Journal of Internal Medicine, vol.46, issue.1, pp.33-41, 2000.
DOI : 10.1164/ajrccm.156.6.9610040

U. Seitzer, C. Swider, F. Stuber, K. Suchnicki, A. Lange et al., TUMOUR NECROSIS FACTOR ALPHA PROMOTER GENE POLYMORPHISM IN SARCOIDOSIS, Cytokine, vol.9, issue.10, pp.787-90, 1997.
DOI : 10.1006/cyto.1997.0224

E. Toussirot and E. Pertuiset, Agents anti-TNF?? et sarco??dose, Mise au point, pp.828-865
DOI : 10.1016/j.revmed.2010.02.007

M. D. Rossman, L. S. Newman, R. P. Baughman, A. Teirstein, S. E. Weinberger et al., A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, vol.23, pp.201-209, 2006.

R. P. Baughman, M. Drent, M. Kavuru, M. A. Judson, U. Costabel et al., Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.7, pp.795-802, 2006.
DOI : 10.1046/j.1365-2036.1999.00027.x

M. A. Judson, R. P. Baughman, U. Costabel, S. Flavin, K. H. Lo et al., Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial, European Respiratory Journal, vol.31, issue.6, pp.1189-96, 2008.
DOI : 10.1183/09031936.00051907

R. P. Baughman, E. E. Lower, and M. Drent, Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them, Sarcoidosis Vasc Diffuse Lung Dis, vol.25, pp.76-89, 2008.

D. Khanna, M. R. Liebling, and J. S. Louie, Etanercept ameliorates sarcoidosis arthritis and skin disease, J Rheumatol, vol.30, pp.1864-1871, 2003.

K. Hobbs, Chronic sarcoid arthritis treated with intraarticular etanercept, Arthritis & Rheumatism, vol.61, issue.3, pp.987-995, 2005.
DOI : 10.1002/art.20936

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.20936/pdf

C. Tuchinda and H. K. Wong, Etanercept for chronic progressive cutaneous sarcoidosis, J Drugs Dermatol, vol.5, pp.538-578, 2006.

L. Roux, K. Streichenberger, N. Vial, C. Petiot, P. Feasson et al., Granulomatous myositis: A clinical study of thirteen cases, Muscle & Nerve, vol.16, issue.2, pp.171-178, 2007.
DOI : 10.7326/0003-4819-48-3-497

J. P. Utz, A. H. Limper, S. Kalra, U. Specks, J. P. Scott et al., Etanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis, Chest, vol.124, issue.1, pp.177-85, 2003.
DOI : 10.1378/chest.124.1.177

R. P. Baughman, E. E. Lower, D. A. Bradley, L. A. Raymond, and A. Kaufman, Etanercept for Refractory Ocular Sarcoidosis, Chest, vol.128, issue.2, pp.1062-1109, 2005.
DOI : 10.1016/S0012-3692(15)50471-6

J. L. Callejas-rubio, N. Ortego-centeno, L. Lopez-perez, and M. N. Benticuaga, Treatment of therapy-resistant sarcoidosis with adalimumab, Clinical Rheumatology, vol.4, issue.4, pp.596-603, 2006.
DOI : 10.7326/0003-4819-135-1-200107030-00010

M. P. Heffernan and D. I. Smith, Adalimumab for Treatment of Cutaneous Sarcoidosis, Archives of Dermatology, vol.142, issue.1, pp.17-26, 2006.
DOI : 10.1001/archderm.142.1.17

M. A. Philips, J. Lynch, and F. H. Azmi, Ulcerative cutaneous sarcoidosis responding to adalimumab, Journal of the American Academy of Dermatology, vol.53, issue.5, p.917, 2005.
DOI : 10.1016/j.jaad.2005.02.023

M. Marnane, T. Lynch, J. Scott, J. Stack, and P. J. Kelly, Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab, Journal of Neurology, vol.129, issue.1, pp.139-179, 2009.
DOI : 10.1007/s00415-009-0077-1

C. Chapelon-abric, ??pid??miologie de la sarco??dose et ses facteurs de risque g??n??tiques et environnementaux, La Revue de M??decine Interne, vol.25, issue.7, pp.494-500, 2004.
DOI : 10.1016/j.revmed.2004.01.011

A. A. Strober and B. E. , Off-label dermatologic uses of anti-TNF-a therapies, J Cutan Med Surg, vol.9, pp.296-302, 2005.

B. A. Cruz, D. D. Reis, and C. A. Araujo, Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab, Rheumatology International, vol.174, issue.12, pp.1181-1184, 2007.
DOI : 10.1007/s00296-007-0359-9

M. Moravan and B. M. Segal, Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil, Neurology, vol.72, issue.4, pp.337-377, 2009.
DOI : 10.1212/01.wnl.0000341278.26993.22

M. Sodhi, K. Pearson, E. S. White, and D. A. Culver, Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis, Respiratory Medicine, vol.103, issue.2, pp.268-73, 2009.
DOI : 10.1016/j.rmed.2008.08.016

A. M. Thielen, C. Barde, J. H. Saurat, and E. Laffitte, Refractory Chronic Cutaneous Sarcoidosis Responsive to Dose Escalation of TNF-Alpha Antagonists, Dermatology, vol.219, issue.1, pp.59-62, 2009.
DOI : 10.1159/000221005

P. J. Hashkes and I. Shajrawi, Sarcoid-related uveitis occurring during etanercept therapy

L. Peno-green, G. Lluberas, T. Kingsley, and S. Brantley, Lung Injury Linked to Etanercept Therapy, Chest, vol.122, issue.5, pp.1858-60, 2002.
DOI : 10.1378/chest.122.5.1858

O. Shea, F. D. Marras, T. K. Inman, and R. D. , Pulmonary sarcoidosis developing during infliximab therapy, Arthritis & Rheumatism, vol.29, issue.6, pp.978-81, 2006.
DOI : 10.1002/art.22351

M. A. Gonzalez-lopez, R. Blanco, M. C. Gonzalez-vela, H. Fernandez-llaca, and V. Rodriguez-valverde, Development of sarcoidosis during etanercept therapy, Arthritis & Rheumatism, vol.74, issue.5, pp.817-837, 2006.
DOI : 10.1002/art.22238

R. Almodovar, M. Izquierdo, P. Zarco, J. Quiros, F. Mazzucchelli et al., Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab

G. Sturfelt, B. Christensson, G. Bynke, and T. Saxne, Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab, J Rheumatol, vol.34, pp.2313-2317, 2007.

F. Dhaille, V. Viseux, A. Caudron, A. Dadban, C. Tribout et al., Cutaneous Sarcoidosis Occurring during Anti-TNF-Alpha Treatment: Report of Two Cases, Dermatology, vol.220, issue.3, pp.234-241
DOI : 10.1159/000275676

K. Verschueren, E. Van-essche, P. Verschueren, V. Taelman, and R. Westhovens, Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients, Clinical Rheumatology, vol.74, issue.3, pp.1969-71, 2007.
DOI : 10.1007/s10067-007-0594-1

R. E. Farah and M. D. Shay, Pulmonary Sarcoidosis Associated with Etanercept Therapy, Pharmacotherapy, vol.9, issue.3, pp.1446-1454, 2007.
DOI : 10.1038/clpt.1981.154

C. Bachmeyer, L. Blum, B. Petitjean, F. Kemiche, and E. Pertuiset, Granulomatous tattoo reaction in a patient treated with etanercept, Journal of the European Academy of Dermatology and Venereology, vol.62, issue.0, pp.550-552, 2007.
DOI : 10.1097/00063198-200209000-00016

A. Al-shami and P. Scheldon, Case report of rheumatoid arthritis patient who developed sarcoidosis while infliximab, Rheumatology, vol.47, p.161, 2008.

E. Toussirot, E. Pertuiset, B. Kantelip, and D. Wendling, Sarcoidosis occuring during anti- TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases, Clin Exp Rheumatol, vol.26, pp.471-476, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00511285

S. Ottaviani, I. Cerf-payrastre, and F. Kemiche, Atypical pulmonary manifestations occuring in patients receiving anti-tumor necrosis factor alpha therapy

T. Ishiguro, N. Takayanagi, K. Kurashima, A. Matsushita, K. Harasawa et al., Development of Sarcoidosis during Etanercept Therapy, Internal Medicine, vol.47, issue.11, pp.1021-1026, 2008.
DOI : 10.2169/internalmedicine.47.0602

D. Van-der-stoep, G. J. Braunstahl, J. Van-zeben, and J. Wouters, Sarcoidosis During Anti-Tumor Necrosis Factor-?? Therapy: No Relapse After Rechallenge, The Journal of Rheumatology, vol.36, issue.12, pp.2847-2855, 2009.
DOI : 10.3899/jrheum.090307

A. Massara, L. Cavazzini, L. Corte, R. Trotta, and F. , Sarcoidosis Appearing During Anti-Tumor Necrosis Factor ?? Therapy: A New ???Class Effect??? Paradoxical Phenomenon. Two Case Reports and Literature Review, Seminars in Arthritis and Rheumatism, vol.39, issue.4, pp.313-322
DOI : 10.1016/j.semarthrit.2008.11.003

S. K. Metyas, R. M. Tadros, and D. G. Arkfeld, Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis, Rheumatology International, vol.359, issue.5
DOI : 10.1007/s00296-008-0691-8

S. Josse, N. Klemmer, S. Moreno-swirc, V. Goeb, T. Lequerre et al., Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient, Joint Bone Spine, vol.76, issue.6, pp.718-727, 2009.
DOI : 10.1016/j.jbspin.2009.02.003

C. I. Daien, A. Monnier, P. Claudepierre, A. Constantin, J. P. Eschard et al., Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases, Rheumatology, vol.57, issue.20, pp.883-889, 2009.
DOI : 10.1111/j.1365-2133.2006.07665.x

URL : https://hal.archives-ouvertes.fr/hal-00465169

S. Takatori, Y. Kamata, T. Murosaki, M. Iwamoto, and S. Minota, Abrupt Development of Sarcoidosis with a Prodromal Increase in Plasma Osteopontin in a Patient with Rheumatoid Arthritis During Treatment with Etanercept, The Journal of Rheumatology, vol.37, issue.1, pp.210-211
DOI : 10.3899/jrheum.090647

I. M. Skoie, K. Wildhagen, and R. Omdal, Development of sarcoidosis following etanercept treatment: a report of three cases, Rheumatology International, vol.178, issue.6
DOI : 10.1084/jem.178.6.2249

S. Izzi, F. Francesconi, P. Visca, A. Altieri, C. De-mutiis et al., Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy, Dermatol Online J, vol.16, p.16

J. Sibilia, Proteine de fusion ou anticorps monoclonal. Quel médicament choisir dans une maladie inflammatoire ?, Med Sci, vol.25, pp.1033-1041, 2009.
DOI : 10.1051/medsci/200925121033

URL : http://www.medecinesciences.org/articles/medsci/pdf/2009/12/medsci20092512p1033.pdf

J. Seneschal, B. Milpied, B. Vergier, S. Lepreux, T. Schaeverbeke et al., Cytokine imbalance with increased production of interferon-?? in psoriasiform eruptions associated with antitumour necrosis factor-?? treatments, British Journal of Dermatology, vol.202, issue.5, pp.1081-1089, 2009.
DOI : 10.7326/0003-4819-130-6-199903160-00004

O. Menard, N. Petit, P. Gillet, A. Gaucher, and Y. Martinet, Association of histologically proven rheumatoid arthritis with pulmonary sarcoidosis, European Respiratory Journal, vol.8, issue.3, pp.472-475, 1995.
DOI : 10.1183/09031936.95.08030472

I. Sezer, M. A. Melikoglu, H. F. Cay, H. Kocabas, and C. Kacar, A co-occurrence of sarcoidosis and ankylosing spondylitis: a case report, Rheumatology International, vol.20, issue.3, pp.605-612, 2008.
DOI : 10.1007/s00296-007-0483-6

. Actuellement, seuls les anticorps monoclonaux sont efficaces et ont une AMM dans les MICI, l'infliximab dans la maladie de Crohn, MC) et la Rectocolite Ulcéro Hémorragique (RCUH), l'adalimumab dans la MC

M. Harrison, W. Dixon, and K. Watson, Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor ?? therapy: results from the British Society for Rheumatology Biologics Register, Annals of the Rheumatic Diseases, vol.68, issue.2, pp.209-224, 2009.
DOI : 10.1136/ard.2007.087288

B. Pérez-zafrilla, Is psoriasis a complication of anti-TNF treatment?, Arthritis Rheumatism, vol.58, p.781, 2008.

A. Collamer, K. Guerrero, and J. Henning, Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action, Arthritis & Rheumatism, vol.44, issue.7, pp.996-1001, 2008.
DOI : 10.1111/j.0022-202X.2005.23864.x

M. Viguier, P. Richette, and H. Bachelez, Paradoxical cutaneous manifestations during anti-TNF therapy, Joint Bone Spine, vol.137, pp.64-71, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00486133

A. Collamer and D. Battafarano, Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action, Arthritis & Rheumatism, vol.44, issue.7, pp.996-1001, 2008.
DOI : 10.1111/j.0022-202X.2005.23864.x

J. Ko, A. Gottlieb, and J. Kerbleski, Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases, Journal of Dermatological Treatment, vol.174, issue.15, pp.100-108, 2009.
DOI : 10.1084/jem.174.6.1461

R. Cuchacovich, C. Espinoza, and Z. Virk, Biologic Therapy(TNF-?? Antagonists)-Induced Psoriasis, JCR: Journal of Clinical Rheumatology, vol.14, issue.6, pp.353-359, 2008.
DOI : 10.1097/RHU.0b013e318190dd88

J. Braun, X. Baraliakos, and J. Listing, Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti???tumor necrosis factor ?? agents, Arthritis & Rheumatism, vol.65, issue.4, pp.639-686, 2007.
DOI : 10.1093/oxfordjournals.aje.a009735

V. Gerloni, I. Pontikaki, and M. Gattinara, Focus on adverse events of tumour necrosis factor ?? blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients, Annals of the Rheumatic Diseases, vol.67, issue.8, pp.1145-52, 2008.
DOI : 10.1136/ard.2007.069484

J. Seneschal, B. Milpied, and B. Vergier, Cytokine imbalance with increased production of interferon-?? in psoriasiform eruptions associated with antitumour necrosis factor-?? treatments, British Journal of Dermatology, vol.202, issue.5, pp.1081-1089, 2009.
DOI : 10.7326/0003-4819-130-6-199903160-00004

H. Ma, L. Napierata, and N. Stedman, Tumor necrosis factor ?? blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells, Arthritis & Rheumatism, vol.10, issue.2, pp.430-470, 2010.
DOI : 10.4049/jimmunol.175.4.2721